Table 2. Reasons for non-compliance with the PSS guideline criteria during the follow-up observation period of two years after PSS diagnosis, taking scenario II as an example.
| Total number of analyzed PSS patients, n (%) | 7947 | (100) |
| Number of PSS patients | ||
| – with guideline-based treatment – without guideline-based treatment |
2937 5010 |
(37.0) (63.0) |
| Reasons for non-compliance with the PSS guideline criteria | ||
| – no regular physiotherapy – prescription of oral antispasticity drugs without BoNT-A treatment – BoNT-A, but without regular physiotherapy – treatment with physiotherapy, BoNT-A, and oral antispasticity drugs; the order of their application, however, does not correspond to the guideline recommendations |
4459 510 8 40 |
(56.1) (6.4) (0.1) (0.5) |
BoNT-A, botulinum toxin type A; PSS, post-stroke spasticity